ETCTN P10500: PHASE 1/EXPANSION STUDY OF TAZEMETOSTAT PLUS BELINOSTAT FOR THE TREATMENT OF RELAPSED OR REFRACTORY LYMPHOMA

Amengual, J. E., Shyr, Y., Durecki, D., Beumer, J. H., Mansukhani, M. M., Williams, M., Kelleher, N., Cherng, H., Pro, B., Schwartz, G. K., LoRusso, P., & Piekarz, R. (2023). ETCTN P10500: PHASE 1/EXPANSION STUDY OF TAZEMETOSTAT PLUS BELINOSTAT FOR THE TREATMENT OF RELAPSED OR REFRACTORY LYMPHOMA. Hematological Oncology, 41(S2), 833–834. Portico. https://doi.org/10.1002/hon.3166_ot14
Authors:
Jennifer E. Amengual
Yu Shyr
Diane E. Durecki
Jan H. Beumer
Mahesh Mansukhani
M. Williams
Neil L. Kelleher
Hua‐Jay J. Cherng
Barbara Pro
Gary K. Schwartz
Patricia LoRusso
Richard Piekarz
Affiliated Authors:
Jennifer E. Amengual
Mahesh Mansukhani
Hua‐Jay J. Cherng
Barbara Pro
Gary K. Schwartz
Publication Type:
Article
Unique ID:
10.1002/hon.3166_ot14
Publication Date:
Data Source:
OpenAlex

Record Created: